Results 151 to 160 of about 1,669,550 (354)

Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon

, 2020
Amber Troy, Sandra Cecilia Esparza‐González, Alicia Bartek, Elizabeth Creissen, Linda Izzo, Angelo Izzo   +5 more
openalex   +2 more sources

VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection [PDF]

, 2019
Sarah van Tol, Colm Atkins, Preeti Bharaj, Kendra N. Johnson, Adam Hage, Alexander N. Freiberg, Ricardo Rajsbaum   +6 more
openalex   +1 more source

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity

Nature, 2009
Hiroki Ishikawa, Zhe Ma, G. Barber
semanticscholar   +1 more source

Type I Interferons [PDF]

, 2014
Theresa K. Resch, Gabriele Reichmann, Zoe Waibler   +2 more
openaire   +1 more source

Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation

Advanced Healthcare Materials, EarlyView.
AngioPlate384 is a 384‐well open‐top platform that automates production of more than 100 miniaturized, perfusable blood vessels embedded in hydrogel and supported by stromal cells. Stromal‐endothelial co‐culture strengthens blood vessel barrier function and yields responses useful for translational planning. Scalable and automation‐ready, it suits drug
Dawn S. Y. Lin, Hanieh Mohammad Hashemi, Kimia Asadi Jozani, Anushree Chakravarty, Sonya Kouthouridis, Jessica Bonanno, Nicky Anvari, Shravanthi Rajasekar, Feng Zhang, Richard Y. Cheng, Narendra Kumar Singh, Luis Miguel Medina, Marc Durante, Yufang He, Boyang Zhang   +14 more
wiley   +1 more source

Glycosylation tips the scales: Novel insights into the dual role of type-I interferons in treated HIV infection

, 2020
Marie‐Kristin Raulf, Bernd Lepenies
openalex   +1 more source

Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis [PDF]

, 2021
Bradley E. Hiller, Yongjun Yin, Yi-Chieh Perng, Ítalo de Araújo Castro, Lindsey E. Fox, Marissa C. Locke, Kristen Monte, Carolina B. López, David M. Ornitz, Deborah J. Lenschow   +9 more
openalex   +1 more source

Type I interferon

Cytokine, 2020
openaire   +2 more sources

Engineered ETS1‐Nanoconjugate Restores Immune Homeostasis through Dual Immune‐Vascular Modulation in Relapsing and Progressive Multiple Sclerosis

Advanced Healthcare Materials, EarlyView.
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang, Si‐Bo Yang, Yan Luo, Xiao‐Di Sun, Bo‐Hao Chang, Da‐Qiang Zhou, Jun‐Jie Jiang, Ya‐Nan Li, Jie‐Hong Wu, Hui‐Juan Jin, Hang Yang, Hang Hu, Yi‐Fan Zhou, Bo Hu   +13 more
wiley   +1 more source

Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation

Advanced Healthcare Materials, EarlyView.
Ferritin‐doped hybrid nanoparticles triggered accurate tumor‐specific hemorrhage for enhanced in situ photothermal therapy and evoked anti‐tumor immunity. Notably, HFn/GA‐Fe specifically induced tumor hemorrhage 12 h after intravenous injection, resulting in visible color darkening. Through photoacoustic imaging, tumor vessels could be clearly observed
Haidong Zha, Xiao Liang, Long Xi, Jiamao Chen, Wenzhao Zhong, Zhen Yuan, Meng Xu, Ying Zheng   +7 more
wiley   +1 more source